GeneralConnection.com ➔ Dictionary
Dictionary Search

acromegaly

Synonyms

Noun

1. acromegalia

2. hypertrophy

Usage
Another FDA no for Camurus’ monthly acromegaly drug Oclaiz - BioWorld News
Camurus’ second CRL for acromegaly drug; Teva details workforce cuts - Endpoints News
Biopharma bites: Summit reverses on proposed raise, Novo Nordisk's cyberattack and Camurus' CRL - FirstWord Pharma
Quiz: Key Decisions in Acromegaly Management - Physician's Weekly
FDA Issues Complete Response Letter For Camurus CAM2029 NDA For Acromegaly - TradingView
Acromegaly - NEJM
Camurus shares fall 7% after FDA rejects acromegaly drug By Investing.com - Investing.com Nigeria
FDA setback for Camurus' acromegaly treatment - Biostock
Immunohistochemical analysis of filamin a expression in acromegaly and its correlation with tumor characteristics and treatment response - Nature
Managing the ‘Invisible’ Symptoms of Acromegaly - Everyday Health
Developments in Pharmacotherapy for Acromegaly: Current and Emerging Approaches - springermedicine.com
Acromegaly Treatment Market Size, Share, Growth 2034 - Fortune Business Insights
Real-World Data Reinforces Paltusotine’s IGF-1 Reductions in Acromegaly, With Leena Shahla, MD - HCPLive
Medical Treatment of Acromegaly - Endocrine Society
Marea reports positive Phase I results for MAR002 trial in acromegaly - Clinical Trials Arena
Sisco: Don’t tie rare disease patients’ lives to the lowest price - The Journal Record
Patients With Acromegaly Have Higher Risk for Cancer - Medscape
Consensus on acromegaly therapeutic outcomes: an update - Nature
Acromegaly Complications: Managing Long-Term Risks - Everyday Health
Debiopharm randomises first patient in Phase III acromegaly trial - Clinical Trials Arena
Oral Acromegaly Drug Performing Well in First Few Patients - Medscape
Acromegaly Market Poised for Significant Expansion During the Forecast Period (2026-2036) as New Treatment Options Emerge | DelveInsight - Yahoo Finance
How to Get Support for Acromegaly - Everyday Health
Acromegaly tied to increased cancer risk that begins before diagnosis - Healio
Chemistry alum’s company wins FDA approval for first oral acromegaly drug - The University of North Carolina at Chapel Hill
Marea Therapeutics to Present Data from Phase 1 Study of MAR002 for the Treatment of Acromegaly at ENDO 2026 - BioSpace
Camurus provides regulatory update on the US NDA for CAM2029 (Oclaiz™) in acromegaly - marketscreener.com
Crinetics wins FDA approval for acromegaly drug, faces competition with Novartis and Ipsen - statnews.com
Women With Acromegaly Face Greater Disease Burden Than Men - Medscape
Growth Hormone-Secreting Pituitary Macroadenoma: Diagnosis of Acromegaly in a Young Adult - Cureus
FDA Approves Crinetics’ Once-Daily Acromegaly Treatment - BioSpace
Daily Oral Option for Acromegaly Wins EU Backing - Medscape
GLP-1s and Muscle Loss; 'Ozempic Personality'; Acromegaly and Cancer Risk - MedPage Today
Acromegaly Market Shows Strong Future Potential with Increasing Industry Investments by 2036 – DelveInsight | Crinetics, Camurus, Chiesi, Debiopharm International SA, AstraZeneca, Marea Therapeutics - Barchart.com
Marea Therapeutics Unveils Positive Topline Phase 1 Data for MAR002 in Acromegaly; Demonstrates Potential for Best-in-Disease Efficacy and Dosing Profile - BioSpace
PALSONIFY (paltusotine) for the Treatment of Acromegaly, USA - Clinical Trials Arena
Crinetics' daily acromegaly pill earns FDA nod for first-line use - FirstWord Pharma
Palsonify, an Oral Therapy for Acromegaly, Gets FDA Approval - Endocrinology Advisor
Camurus' hormone disorder drug expected to be approved in 2027 af - Global Banking & Finance Review
Crinetics breaks the commercial barrier with FDA nod for oral acromegaly med Palsonify - Fierce Pharma
FDA Approves First Once-Daily Oral Therapy for Acromegaly - Conexiant
AI spots early facial changes in patients with acromegaly - Medical Xpress
Marea takes drug for rare hormone disease acromegaly to Phase 2 - Endpoints News
Comparative PET Imaging for Radiosurgical Target Delineation in Residual Acromegaly - Journal of Nuclear Medicine
Paltusotine Receives FDA Approval to Treat Acromegaly in Adults - Pharmacy Times
Crinetics Pharmaceuticals Announces Submission of Marketing - GlobeNewswire
Paltusotine FDA Approved for Acromegaly in Adults - AJMC
Rare but Real: Navigating Acromegaly Diagnosis and Treatment - Physician's Weekly
Fatigue in acromegaly patients: a scoping review - Frontiers
Acromegaly linked to higher cancer risk - News-Medical
First subject enrolled in Marea’s Phase I trial for acromegaly treatment - Clinical Trials Arena
Lorazepam-induced full resolution of catatonia and psychosis in Parkinson’s disease with acromegaly: a case report - Frontiers
From Awareness to Action: Exceeding Goals in Rare Disease Lead Generation - The Shorty Awards
EU approves first once-daily pill for acromegaly from Crinetics - Stock Titan
With FDA Nod in Rare Hormone Disease, Crinetics Can Challenge Blockbuster Meds From Novartis, Ipsen - MedCity News
Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations - GlobeNewswire
Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults - Yahoo Finance
Weekly Buzz: FDA Okays Saphnelo Pen, EC Clears Acromegaly Drug, SNGX Slumps, LGND Snaps Up XOMA - RTTNews
Once-Monthly GLP-1 Shot? Mangos for Blood Sugar Control; New Acromegaly Treatment - MedPage Today
Palsonify Receives FDA Approval for Treatment of Adults with Acromegaly - Pharmaceutical Executive
Room for growth in acromegaly as Crinetics’ Palsonify cleared - BioWorld News
Crinetics earnings on deck after European acromegaly drug win - Investing.com
AI Finds Life Shortening Hormone Disorder Using Only Hand Photos - SciTechDaily
Crinetics Pharmaceuticals' PALSONIFY® Receives European Union Approval as First Once-Daily Oral Treatment for Acromegaly - Quiver Quantitative
AstraZeneca prunes asthma, rare disease pipeline, cultivates cancer portfolio - BioSpace
Crinetics submits application for acromegaly drug in Brazil - Investing.com
A Simple Photo of Your Hand Could Detect a Rare Health Disorder - ScienceAlert
US FDA approves Crinetics' oral pill for rare hormone disorder - Reuters
Crinetics reveals new data from acromegaly therapy programme - Clinical Trials Arena
The Bull Case For Crinetics Pharmaceuticals (CRNX) Could Change Following EU Nod For Oral Acromegaly Drug PALSONIFY - Yahoo Finance
Marea Therapeutics Enrolls First Participant in Phase 1 Clinical Study Evaluating MAR002 for Acromegaly - Business Wire
FDA accepts Camurus’ resubmission for acromegaly treatment Oclaiz - Investing.com
A simple hand photo may be the key to detecting a serious disease - ScienceDaily
Crinetics receives EU approval for acromegaly drug Palsonify - Investing.com
Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly - BioSpace
Acromegaly - Nature
PANTHERx® Rare Selected by Chiesi for the Distribution of MYCAPSSA® - PR Newswire
Gigantism and Acromegaly: Background, Pathophysiology and Etiology, Epidemiology - Medscape
Patient perspectives on acromegaly disease burden: insights from a community meeting - Frontiers
Brazil gets filing for once-daily acromegaly pill backed by 18 trials - Stock Titan
Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment - Frontiers
Individualized acromegaly treatment: Is stereotactic radiation therapy changing the paradigm? - Frontiers
Somatostatin Analogs Market Size, Share | CAGR of 13.4% - Market.us
Surgery for acromegaly: Indications and goals - Frontiers
Acromegaly Awareness Day shines light on rare condition that is hard to diagnose - CTV News
The acromegaly lipodystrophy - Frontiers
Molecular targets in acromegaly - Frontiers
Acromegaly - NEJM
Crinetics earnings on deck after European acromegaly drug win By Investing.com - Investing.com Nigeria
Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine - Nature
Insulin Resistance in Patients With Acromegaly - Frontiers
Acromegaly and Colorectal Neoplasm: An Update - Frontiers
Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire
Acromegaly - NEJM
A Consensus Statement on acromegaly therapeutic outcomes - Nature
Marea Therapeutics Presents Preclinical Data on Novel Growth Hormone Receptor Antagonist Antibody, MAR002, for the Treatment of Acromegaly at ENDO 2025 - BioSpace
Crinetics Pharmaceuticals Presents New Long-Term Data on PALSONIFY for Acromegaly at ENDO 2025 - Quiver Quantitative
Case report: Treatment of psychiatric symptoms for an acromegalic patient with pituitary adenoma - Frontiers
Eucaloric Very-Low-Carbohydrate Ketogenic Diet in Acromegaly Treatment - NEJM
Acromegaly Causes Erectile Dysfunction: Understanding the Link and Supportive Strategies - Portal CNJ
Foreign Language Equivalents
Foreign Language Equivalents of 'acromegaly'
Language Equivalent   Language Equivalent
French acromégalie    Spanish
Misspellings - Typos
acromealy,   acromegally,   acromrgaly,   acroomegaly,   acormegaly,   acrromegaly,   axromegaly,   arcomegaly,   scromegaly,   acro,egaly,   aacromegaly,   acromegalt,   acromehaly,   acromegaky,   acromgealy,   acromegsly,   acromgaly,   acromegal,   acromeglay,   acromegalu,   acrommegaly,   acrpmegaly,   acromegalyy,   acromegayl,   acromegaaly,   cromegaly,   acromefaly,   acromeegaly,   avromegaly,   acromeggaly,   acomegaly,   acromeagly,   acromwgaly,   acroegaly,   acroemgaly,   accromegaly,   aromegaly,   aceomegaly,   acromega;y,   acromegay,   actomegaly,   acronegaly,   acrmegaly,   caromegaly,   acrimegaly,   acrmoegaly,   acromegly
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z